Clinical
Agios shares slide 25% as Novo Nordisk sickle cell data rattles rival drug programme
Shares in Agios Pharmaceuticals fell 25 per cent on Monday after Danish pharmaceutical group Novo Nordisk unveiled encouraging clinical data for its experimental sickle cell disease therapy, intensifying competitive pressure on the…
